Riliprubart is Designated as an Orphan Drug in the US Image Credits: Yahoo Finance Announcement The US Food and Drug Administration approved Rilpivirine, positioning it as an orphan drug designation. Rilipubart, an investigational treatment for antibody-mediated rejection (AMR) in solid organ t...
Recordati’s Agreement with Amarin Image Credits: Fierce Pharma Announcement Recordati, an international pharmaceutical company, signed a license and supply agreement with Amarin, a company known for the treatment of cardiovascular diseases. The agreement’s purpose is to present a ma...
Verastem Oncology’s oral KRAS G12D (ON/OFF) Inhibitor in the First Patient Image Credits: Stock Titan Announcement Verastem Oncology, a biopharmaceutical company known for introducing new medicines for patients suffering from cancer-related RAS/MAPK, has announced that the first patient h...
Emery and Fortrea Pharma’s Collaboration Image Credits: Stock Titan Announcement Fortrea pharma, a known contract research organization (CRO), entered into a collaboration with Emery pharma, an analytical and bioanalytical CRO. The collaboration is initiated to deliver testing services un...
Zambon Approval and Entry into China Image Credits: Farmacia Rubino Announcement A multinational chemical pharmaceutical company, Zambon, known for its innovative care and cure, has received approval from Chinese regulatory authorities. Zambon received approval due to its vigorous local clinica...
Susan G. Komen’s Investment in Breast Cancer Research Image Credits: Susan G Komen Announcement Susan G. Komen, a known breast cancer organization, has invested $10.8 million in new research that will accelerate innovation in science and deliver effective solutions to patients suffering f...
SpaceX’s Entry in Vietnam? Image Credits: The Economic Times Announcement SpaceX, an American space technology company, has planned an expansion in Vietnam, expecting an opportunity in the healthcare market of the region that is open to adopting a digital transformation. Director of enter...
Questions on FDA Conditions Image Credits: Biospace New Regulatory Pathway At Bio2025, rare diseases leaders Yale, Ultragenyx, and Amylyx raised a few questions on the new regulatory pathways introduced by Marty Makary, an FDA commissioner. The leaders also acknowledged the efforts and addition...
GE Healthcare’s Approach to the Latest Technological Advancement Image Credits: MedTech Spectrum Announcement This year, at the Society of Nuclear Medicine and Molecular Imaging annual meeting, GE Healthcare highlighted an innovative technological solution by presenting an advanced portfo...
CHMP’s Opinion on Sarclisa Image Credits: Pharmaceutical Technology Announcement The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of Sarclisa, combining dexamethasone, bortezomib, and lenalidomide for the induction...
